Back to top
more

West Pharmaceutical Services (WST)

(Real Time Quote from BATS)

$344.01 USD

344.01
365,868

-2.08 (-0.60%)

Updated Aug 28, 2026 09:44 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 248)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy

by Zacks Equity Research

ENTX posts positive PK data for its first oral GLP-2 therapy, signaling a potential breakthrough in short bowel syndrome treatment.

Zacks Equity Research

BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care

by Zacks Equity Research

BrainsWay shares surge after the FDA cleared its accelerated Deep TMS protocol, offering faster depression treatment with strong clinical results.

Zacks Equity Research

CAH Strengthens Distribution With New Consumer Health Logistics Hub

by Zacks Equity Research

Cardinal Health opens a 350,000-square-foot Consumer Health Logistics Center in Ohio, strengthening its pharmaceutical supply chain and advancing its multiyear infrastructure expansion strategy.

Zacks Equity Research

GEHC Expands Women's Health Portfolio With AI-Enabled Voluson

by Zacks Equity Research

GE HealthCare debuts AI-powered Voluson Performance ultrasound systems, enhancing women's health imaging with faster, smarter diagnostics.

Zacks Equity Research

ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5

by Zacks Equity Research

Intuitive Surgical unveils real-time surgical insights on its da Vinci 5, enhancing precision, safety, and efficiency with advanced software features.

Zacks Equity Research

GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio

by Zacks Equity Research

GE HealthCare moves to strengthen its neurology portfolio by acquiring icometrix, aiming to integrate AI-driven brain MRI solutions into its imaging platforms.

Zacks Equity Research

MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care

by Zacks Equity Research

Merit Medical secures CE Mark for Embosphere, expanding its use in knee osteoarthritis treatment with a minimally invasive alternative.

Nalak Das headshot

5 Must-Buy Laggards of 2025 With Double-Digit Short-Term Price Upside

by Nalak Das

Five lagging stocks, namely, AIZ, DOCU, DUOL, WST and ZBRA, now offer strong short-term upside despite 2025's AI-driven rally.

Zacks Equity Research

Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study

by Zacks Equity Research

PLSE wins FDA IDE approval for its NANOCLAMP AF study, advancing nsPFA tech as a novel option in atrial fibrillation surgery.

Zacks Equity Research

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

by Zacks Equity Research

OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.